ATX 8.96% 6.1¢ amplia therapeutics limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-40

  1. 437 Posts.
    lightbulb Created with Sketch. 211
    Thanks. So it’s important to know when the 26th gets included and expected follow up from the time of 26th starting in trial to estimate conservative time frame. Median duration of gem/nab paclitaxel in the original Mpact trial was 4 months. So if we use that assumption, and ATX saying mid- year for results, let’s say June 30, working back 4 months means 26th should have been enrolled end Feb.
    However if they get lucky and all 6 + objective responses they need to pass futility occur in first handful of patients, that’s great!
 
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
(20min delay)
Last
6.1¢
Change
-0.006(8.96%)
Mkt cap ! $16.56M
Open High Low Value Volume
6.5¢ 6.5¢ 5.6¢ $42.68K 709.9K

Buyers (Bids)

No. Vol. Price($)
1 642 5.8¢
 

Sellers (Offers)

Price($) Vol. No.
6.1¢ 236421 1
View Market Depth
Last trade - 16.10pm 20/06/2024 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.